Bgm (BGM) Long-Term Investments (2019 - 2025)
Bgm (BGM) posted quarterly Long-Term Investments of $11.5 million for Q3 2025, up 242.14% year-over-year from $3.4 million in Q3 2024, and up 264.5% quarter-over-quarter from $3.2 million in Q1 2025.
Bgm (BGM) Long-Term Investments (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Long-Term Investments for 7 consecutive years, with $11.5 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Long-Term Investments rose 242.14% year-over-year to $11.5 million; the TTM figure through Sep 2025 stood at $11.5 million (up 242.14% YoY), while the FY2025 annual figure was $11.5 million, up 242.14% from the prior year.
- Long-Term Investments grew to $11.5 million in Q3 2025 per BGM's latest filing, from $3.2 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $681.8 billion in Q1 2022 and bottomed at $606005.0 in Q3 2023.
- Historically, Long-Term Investments has averaged $210.0 billion across 5 years, with a median of $3.4 million in 2024.
- Annual changes were most pronounced in 2023 — Long-Term Investments dropped 10.38% — and 2024, when it jumped 454.42%.
- Bgm's Long-Term Investments stood at $639466.0 in 2021, then fell by 3.42% to $617570.0 in 2022, then retreated by 1.87% to $606005.0 in 2023, then surged by 454.42% to $3.4 million in 2024, then jumped by 242.14% to $11.5 million in 2025.
- Business Quant data shows BGM's Long-Term Investments at $11.5 million in Q3 2025, $3.2 million in Q1 2025, and $3.4 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 60.00 Mn |
| 10 | Bgm | 29.89 Mn | 20.07 Mn | - | 11.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11.50 Mn |
| Mar 31, 2025 | 3.15 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Sep 30, 2023 | 606,005.00 |
| Mar 31, 2023 | 611.03 Bn |
| Sep 30, 2022 | 617,570.00 |
| Mar 31, 2022 | 681.82 Bn |
| Sep 30, 2021 | 639,466.00 |
| Mar 31, 2021 | 596.99 Bn |
| Sep 30, 2020 | 540,517.00 |
| Sep 30, 2019 | 539,680.00 |